Combination Therapy with Doxorubicin-Loaded Reduced Albumin Nanoparticles and Focused Ultrasound in Mouse Breast Cancer Xenografts
Open Access
- 7 September 2020
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 13 (9) , 235
Abstract
Because chemotherapeutic drugs are often associated with serious side effects, the central topic in modern drug delivery is maximizing the localization of drugs at the target while minimizing non-specific drug interactions at unwanted regions. To address this issue, biocompatible nanoparticles have been developed to enhance the drug half-life while minimizing the associated toxicity. Nevertheless, relying solely on the enhanced half-life and enhanced permeability and retention (EPR) effects has been ineffective, and designing stimulus-sensitive nanoparticles to introduce the precise control of drug release has been desired. In this paper, we introduce a pH-sensitive, reduced albumin nanoparticle in combination with focused ultrasound treatment. Not only did these nanoparticles have superior therapeutic efficacy and toxicity profiles when compared to the free drugs in xenograft mouse models, but we were also able to show that the albumin nanoparticles reported in this paper were more suitable than other types of non-reduced albumin nanoparticles as vehicles for drug delivery. As such, we believe that the albumin nanoparticles presented in this paper with desirable characteristics including the induction of strong anti-tumor response, precise control, and superior safety profiles hold strong potential for preclinical and clinical anticancer therapy.Keywords
This publication has 31 references indexed in Scilit:
- Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancerScientific Reports, 2016
- Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic CancerCancer Research, 2015
- Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic ImplicationsMolecular Biology International, 2014
- Doxorubicin, DNA torsion, and chromatin dynamicsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014
- Nanoparticle mediated non-covalent drug deliveryAdvanced Drug Delivery Reviews, 2013
- Albumin nanoparticles with predictable size by desolvation procedureJournal of Microencapsulation, 2011
- Covalently Linking Poly(lactic‐co‐glycolic acid) Nanoparticles to Microbubbles Before Intravenous Injection Improves their Ultrasound‐Targeted Delivery to Skeletal MuscleSmall, 2011
- International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent ChemotherapyJNCI: Journal of the National Cancer Institute, 2009
- Doxorubicin CardiotoxicityJAMA, 1978
- Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervalsJAMA, 1978